Viewing Study NCT04439305


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
Study NCT ID: NCT04439305
Status: WITHDRAWN
Last Update Posted: 2020-07-20
First Post: 2020-06-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module